Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 96

1.

Differential Helicobacter pylori Plasticity in the Gastric Niche of Subjects at Increased Gastric Cancer Risk.

Casarotto M, Pratesi C, Bidoli E, Maiero S, Magris R, Steffan A, Basaglia G, Canzonieri V, De Re V, Cannizzaro R, Zanussi S.

Pathogens. 2019 May 18;8(2). pii: E65. doi: 10.3390/pathogens8020065.

2.

Polymorphism in Toll-Like Receptors and Helicobacter Pylori Motility in Autoimmune Atrophic Gastritis and Gastric Cancer.

De Re V, Repetto O, De Zorzi M, Casarotto M, Tedeschi M, Giuffrida P, Lenti MV, Magris R, Miolo G, Mazzon C, Zanette G, Alessandrini L, Canzonieri V, Caggiari L, Zanussi S, Steffan A, Di Sabatino A, Cannizzaro R.

Cancers (Basel). 2019 May 10;11(5). pii: E648. doi: 10.3390/cancers11050648.

3.

Complete and Durable Response to Combined Chemo/Radiation Therapy in EGFR Wild-Type Lung Adenocarcinoma with Diffuse Brain Metastases.

Santeufemia DA, Palmieri G, Cossu A, De Re V, Caggiari L, De Zorzi M, Casula M, Sini MC, Baldino G, Dedola MF, Corona G, Miolo G.

Diagnostics (Basel). 2019 Apr 11;9(2). pii: E42. doi: 10.3390/diagnostics9020042.

4.

Clinical Significance of Polymorphisms in Immune Response Genes in Hepatitis C-Related Hepatocellular Carcinoma.

De Re V, Tornesello ML, De Zorzi M, Caggiari L, Pezzuto F, Leone P, Racanelli V, Lauletta G, Gragnani L, Buonadonna A, Vaccher E, Zignego AL, Steffan A, Buonaguro FM.

Front Microbiol. 2019 Mar 15;10:475. doi: 10.3389/fmicb.2019.00475. eCollection 2019.

5.

Cancer Diagnostic and Predictive Biomarkers 2018.

Buonaguro FM, Caposio P, Tornesello ML, De Re V, Franco R.

Biomed Res Int. 2019 Jan 8;2019:3879015. doi: 10.1155/2019/3879015. eCollection 2019. No abstract available.

6.

Proteomic Identification of Plasma Biomarkers in Children and Adolescents with Recurrent Hodgkin Lymphoma.

Repetto O, Mussolin L, Elia C, Martina L, Bianchi M, Buffardi S, Sala A, Burnelli R, Mascarin M, De Re V.

J Cancer. 2018 Nov 24;9(24):4650-4658. doi: 10.7150/jca.27560. eCollection 2018.

7.

Molecular Features Distinguish Gastric Cancer Subtypes.

De Re V.

Int J Mol Sci. 2018 Oct 11;19(10). pii: E3121. doi: 10.3390/ijms19103121.

8.

Proposed Molecular and miRNA Classification of Gastric Cancer.

Alessandrini L, Manchi M, De Re V, Dolcetti R, Canzonieri V.

Int J Mol Sci. 2018 Jun 6;19(6). pii: E1683. doi: 10.3390/ijms19061683. Review.

9.

Molecular and Pathological Features of Gastric Cancer in Lynch Syndrome and Familial Adenomatous Polyposis.

Fornasarig M, Magris R, De Re V, Bidoli E, Canzonieri V, Maiero S, Viel A, Cannizzaro R.

Int J Mol Sci. 2018 Jun 6;19(6). pii: E1682. doi: 10.3390/ijms19061682.

10.

Immunotherapy for Gastric Cancer: Time for a Personalized Approach?

Dolcetti R, De Re V, Canzonieri V.

Int J Mol Sci. 2018 May 29;19(6). pii: E1602. doi: 10.3390/ijms19061602. Review.

11.

Quantitative Proteomic Approach Targeted to Fibrinogen β Chain in Tissue Gastric Carcinoma.

Repetto O, Maiero S, Magris R, Miolo G, Cozzi MR, Steffan A, Canzonieri V, Cannizzaro R, De Re V.

Int J Mol Sci. 2018 Mar 7;19(3). pii: E759. doi: 10.3390/ijms19030759.

12.

Use of Metabolomics as a Complementary Omic Approach to Implement Risk Criteria for First-Degree Relatives of Gastric Cancer Patients.

Corona G, Cannizzaro R, Miolo G, Caggiari L, De Zorzi M, Repetto O, Steffan A, De Re V.

Int J Mol Sci. 2018 Mar 7;19(3). pii: E750. doi: 10.3390/ijms19030750.

13.

Characterizing Metastatic HER2-Positive Gastric Cancer at the CDH1 Haplotype.

Caggiari L, Miolo G, Buonadonna A, Basile D, Santeufemia DA, Cossu A, Palmieri G, De Zorzi M, Fornasarig M, Alessandrini L, Canzonieri V, Lo Re G, Puglisi F, Steffan A, Cannizzaro R, De Re V.

Int J Mol Sci. 2017 Dec 23;19(1). pii: E47. doi: 10.3390/ijms19010047.

14.

HLA-G+3027 polymorphism is associated with tumor relapse in pediatric Hodgkin's lymphoma.

De Re V, Caggiari L, Mussolin L, d'Amore ES, Famengo B, De Zorzi M, Martina L, Elia C, Pillon M, Santoro N, Muggeo P, Buffardi S, Bianchi M, Sala A, Farruggia P, Vinti L, Carosella ED, Burnelli R, Mascarin M.

Oncotarget. 2017 Nov 18;8(62):105957-105970. doi: 10.18632/oncotarget.22515. eCollection 2017 Dec 1.

15.

A new mutation of the CDH1 gene in a patient with an aggressive signet-ring cell carcinoma of the stomach.

Caggiari L, Miolo G, Canzonieri V, De Zorzi M, Alessandrini L, Corona G, Cannizzaro R, Santeufemia DA, Cossu A, Buonadonna A, De Re V.

Cancer Biol Ther. 2018 Apr 3;19(4):254-259. doi: 10.1080/15384047.2017.1394540. Epub 2017 Nov 13.

16.

Notch4 and mhc class II polymorphisms are associated with hcv-related benign and malignant lymphoproliferative diseases.

Gragnani L, Fognani E, De Re V, Libra M, Garozzo A, Caini P, Cerretelli G, Giovannelli A, Lorini S, Monti M, Bagnoli S, Piaceri I, Zignego AL.

Oncotarget. 2017 May 6;8(42):71528-71535. doi: 10.18632/oncotarget.17655. eCollection 2017 Sep 22.

17.

New Insights into the Pathogenesis of Celiac Disease.

De Re V, Magris R, Cannizzaro R.

Front Med (Lausanne). 2017 Aug 31;4:137. doi: 10.3389/fmed.2017.00137. eCollection 2017. Review.

18.

Coagulation and fibrinolysis in gastric cancer.

Repetto O, De Re V.

Ann N Y Acad Sci. 2017 Sep;1404(1):27-48. doi: 10.1111/nyas.13454. Epub 2017 Aug 22. Review.

PMID:
28833193
19.

Protein signature characterizing Helicobacter pylori strains of patients with autoimmune atrophic gastritis, duodenal ulcer and gastric cancer.

De Re V, Repetto O, Zanussi S, Casarotto M, Caggiari L, Canzonieri V, Cannizzaro R.

Infect Agent Cancer. 2017 Apr 27;12:22. doi: 10.1186/s13027-017-0133-x. eCollection 2017.

20.

Identification of protein clusters predictive of tumor response in rectal cancer patients receiving neoadjuvant chemo-radiotherapy.

Repetto O, De Re V, De Paoli A, Belluco C, Alessandrini L, Canzonieri V, Cannizzaro R.

Oncotarget. 2017 Apr 25;8(17):28328-28341. doi: 10.18632/oncotarget.16053.

Supplemental Content

Loading ...
Support Center